InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Bandari Jathin, Directeur Médical. Director active across 1 companies, notably Protara Therapeutics, Inc.. Cumulatively, 2 disclosures have been published. The latest transaction was disclosed on 10 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
013,500 shares0
Common Stock
SEC:0001209191-22-003084·
013,500 shares0
Common Stock
SEC:0001209191-22-003084:0·
2 of 2 declarations
About Bandari Jathin
Jathin Bandari is the Chief Medical Officer at Protara Therapeutics, Inc. He is responsible for the company's medical and research strategies. With a strong background in the medical field, Bandari contributes to the innovation and effectiveness of treatments developed by Protara.
